Author

D. Amoako

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

J. Bhiman· 2 shared J. Everatt· 2 shared N. Wolter· 2 shared A. Bodenstein· 1 shared A. Van Gottberg· 1 shared A. von Gottberg· 1 shared B. Lambson· 1 shared C. Cohen· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Bhiman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection

S. H. Ko, P. Radecki, F. Belinky, J. Bhiman, S. Meiring, J. Kleynhans, D. Amoako, V. Guerra Canedo, M. Lucas, D. Kekana, N. Martinson, L. Lebina, J. Everatt, S. Tempia, T. Bylund, , E. A. Boritz

This study shows that advanced HIV infection leads to high intra-host SARS-CoV-2 spike diversity and adaptive evolution, potentially contributing to new variants of concern.

bioRxiv · Jan 5, 2024 · PreprintMicrobiology

SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1

S. Richardson, T. Motlou, M. van der Mescht, B. Lambson, J. Everatt, D. Amoako, A. Van Gottberg, N. Wolter, Z. de Beer, T. Roma de Villiers, A. Bodenstein, G. van den Berg, T. M. Rossouw, M. Boswell, V. Ueckermann, , P. Moore

This study compares the neutralizing antibody responses to SARS-CoV-2 BA.4 and BA.1, finding BA.4 induces more cross-reactive antibodies, suggesting potential benefits for next-generation vaccines.

bioRxiv · Jul 14, 2022 · PreprintImmunology